US Patent Issued to Innovate Therapeutics on Dec. 23 for "Centanafadine multiphasic controlled-release pharmaceutical formulation" (New Jersey Inventor)

ALEXANDRIA, Va., Dec. 23 -- United States Patent no. 12,502,358, issued on Dec. 23, was assigned to Innovate Therapeutics LLC (Princeton, N.J.).

"Centanafadine multiphasic controlled-release pharmaceutical formulation" was invented by Jayendrakumar Dasharathlal Patel (Robbinsville, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A centanafadine multiphasic controlled-release pharmaceutical formulation comprising a centanafadine continuous phase surrounding a centanafadine particulate phase, wherein the amount of centanafadine contained in the centanafadine continuous phase facilitates a first release rate of the centanafadine, and the amount of centanafadine contained in the centanafadine particulate pha...